Koyfin Home > Directory > Health Care > Portola Pharma > EV / EBITDA (ltm)

Portola Pharma EV / EBITDA (ltm) Chart (PTLA)

Portola Pharma annual/quarterly EV / EBITDA (ltm) from 2013 to 2013. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Portola Pharma EV / EBITDA (ltm) for the quarter ending August 08, 2013 was 77.15 a -0.36% decrease of -0.28 year over year
  • Portola Pharma EV / EBITDA (ltm) for the last 12 months ending August 08, 2013 was 77.15 a -0.36% decrease of -0.28 year over year
  • Portola Pharma Annual EV / EBITDA (ltm) for 2013 was 77.15 a 0.67% increase of 0.51 from 2012
  • Portola Pharma Annual EV / EBITDA (ltm) for 2013 was 76.64 a -2.33% decrease of -1.78 from 2012
  • Portola Pharma Annual EV / EBITDA (ltm) for 2013 was 78.42 a 1.26% increase of 0.99 from 2012
Other Valuation Metrics:
  • Portola Pharma Market Cap for the quarter ending March 03, 2018 was $2,136m a -49.96% decrease of -1,067m year over year
  • Portola Pharma Price / Book for the quarter ending March 03, 2018 was 6.15 a -222.27% decrease of -13.67 year over year
  • Portola Pharma Enterprise Value for the quarter ending March 03, 2018 was $1,780m a -67.70% decrease of -1,205m year over year
View Chart On Koyfin

Quarterly PTLA EV / EBITDA (ltm) Data

08/201377.15
08/201376.64
08/201378.42
08/201377.43
08/201378.22
08/201377.07
08/201380.08
08/201381.23
08/201377.91
07/201377.35

Annual PTLA EV / EBITDA (ltm) Data

201377.15
201376.64
201378.42
201377.43
201378.22
201377.07
201380.08
201381.23
201377.91
201377.35